• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析患者的残余肾功能可能预防高铝血症。

Residual renal function in hemodialysis patients may protect against hyperaluminemia.

作者信息

Altmann P, Butter K C, Plowman D, Chaput de Saintonge D M, Cunningham J, Marsh F P

机构信息

Department of Nephrology, London Hospital, United Kingdom.

出版信息

Kidney Int. 1987 Nov;32(5):710-3. doi: 10.1038/ki.1987.264.

DOI:10.1038/ki.1987.264
PMID:3430958
Abstract

We investigated 106 home hemodialysis patients whose mean [+/- SEM] serum aluminum (Al) concentration was 60.9 +/- 4.1 micrograms/liter. Serum Al concentration was inversely related to daily urine output (r = -0.52, P less than 0.001). Urine volume and measurements of Al exposure were included in a multivariate analysis of serum Al concentration in the 62 patients whose urine output was greater than 10 ml/day. The multiple correlation coefficient (r) was 0.70 (P less than 0.001) and the percentage contributions to r2 (indicating the relative importance of each factor) were: urine output 57%, oral Al intake 36%, total dialysis hours 7%. The additional contribution from cumulative water Al was negligible. In a subgroup of 26 patients with a urine output exceeding 10 ml/day, urinary Al excretion averaged 15.4 micrograms/day, and renal Al clearance and serum Al concentration were inversely related (r = -0.69, P less than 0.001). We conclude that Al-containing phosphate binders were a more important source of Al than was dialysate in these patients and that residual renal function can reduce the severity of hyperaluminemia in hemodialysis patients.

摘要

我们对106名家庭血液透析患者进行了研究,这些患者的血清铝(Al)浓度均值为60.9±4.1微克/升(均值±标准误)。血清铝浓度与每日尿量呈负相关(r = -0.52,P<0.001)。在尿量大于10毫升/天的62名患者中,将尿量和铝暴露量的测量纳入血清铝浓度的多变量分析。多重相关系数(r)为0.70(P<0.001),对r2的贡献率(表明各因素的相对重要性)分别为:尿量57%,口服铝摄入量36%,总透析时长7%。累积水中铝的额外贡献可忽略不计。在尿量超过10毫升/天的26名患者亚组中,尿铝排泄平均为15.4微克/天,肾铝清除率与血清铝浓度呈负相关(r = -0.69,P<0.001)。我们得出结论,在这些患者中,含铝磷结合剂是比透析液更重要的铝来源,并且残余肾功能可降低血液透析患者高铝血症的严重程度。

相似文献

1
Residual renal function in hemodialysis patients may protect against hyperaluminemia.血液透析患者的残余肾功能可能预防高铝血症。
Kidney Int. 1987 Nov;32(5):710-3. doi: 10.1038/ki.1987.264.
2
Seasonal variations in serum aluminum concentrations.血清铝浓度的季节性变化。
Pharmacol Toxicol. 1988 Feb;62(2):80-3. doi: 10.1111/j.1600-0773.1988.tb01850.x.
3
Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD).持续非卧床腹膜透析(CAPD)患者血清、透析液、尿液和骨骼中的铝浓度。
Clin Nephrol. 1989 Sep;32(3):133-8.
4
[Hyperaluminemia in chronic hemodialysis patients. Evaluation of the respective roles of dialysate aluminum and oral aluminum hydroxide].
Nephrologie. 1983;4(3):129-33.
5
Relationship of body iron status and serum aluminum in chronic renal insufficiency patients not taking any aluminum-containing drugs.未服用任何含铝药物的慢性肾功能不全患者体内铁状态与血清铝的关系。
Am J Nephrol. 1995;15(2):118-22. doi: 10.1159/000168815.
6
Risk factors and consequences of hyperaluminemia in a peritoneal dialysis cohort.腹膜透析队列中高铝血症的危险因素和后果。
Perit Dial Int. 2012 Nov-Dec;32(6):645-51. doi: 10.3747/pdi.2011.00203. Epub 2012 Aug 1.
7
Serum concentration and peritoneal transfer of aluminum during treatment by continuous ambulatory peritoneal dialysis.持续性非卧床腹膜透析治疗期间铝的血清浓度及腹膜转运情况
Kidney Int. 1984 Jun;25(6):919-24. doi: 10.1038/ki.1984.110.
8
C-terminal agrin fragment (CAF) as a serum biomarker for residual renal function in peritoneal dialysis patients.C 端聚集蛋白聚糖片段(CAF)作为腹膜透析患者残余肾功能的血清生物标志物。
Int Urol Nephrol. 2015 Feb;47(2):391-6. doi: 10.1007/s11255-014-0852-5. Epub 2014 Oct 29.
9
[Comparison of six radionuclidic and non-radionuclidic methods for the assessment of glomerular filtration rate in patients with chronic renal failure].[六种放射性核素及非放射性核素方法评估慢性肾衰竭患者肾小球滤过率的比较]
Hell J Nucl Med. 2006 May-Aug;9(2):133-40.
10
Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water.饮用水中单体无机铝和水合硅酸铝的允许总浓度。
Crit Rev Toxicol. 2012 May;42(5):358-442. doi: 10.3109/10408444.2012.674101.

引用本文的文献

1
Risk factors and consequences of hyperaluminemia in a peritoneal dialysis cohort.腹膜透析队列中高铝血症的危险因素和后果。
Perit Dial Int. 2012 Nov-Dec;32(6):645-51. doi: 10.3747/pdi.2011.00203. Epub 2012 Aug 1.
2
Disturbance of cerebral function in people exposed to drinking water contaminated with aluminium sulphate: retrospective study of the Camelford water incident.接触受硫酸铝污染饮用水人群的脑功能障碍:卡梅尔福德水事件的回顾性研究
BMJ. 1999 Sep 25;319(7213):807-11. doi: 10.1136/bmj.319.7213.807.
3
Effects of residual renal function in haemodialysis patients.
血液透析患者残余肾功能的影响。
Int Urol Nephrol. 1994;26(1):125-31. doi: 10.1007/BF02768252.
4
Residual renal function in children on haemodialysis and peritoneal dialysis therapy.接受血液透析和腹膜透析治疗的儿童的残余肾功能
Pediatr Nephrol. 1994 Oct;8(5):579-83. doi: 10.1007/BF00858132.